Press Releases Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Delayed Nasdaq Other stock markets 02:53:56 2024-06-06 pm EDT			5-day change	1st Jan Change
3.64 ^USD	0.00%		+0.55%	-16.89%

May. 09	Transcript : Eton Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Eton Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results	May. 09	GL
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference	May. 01	GL
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	Apr. 30	GL
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	Apr. 30	AQ
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024	Apr. 29	GL
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	Mar. 25	AQ
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	Mar. 22	AQ
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	Mar. 22	GL
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 14	GL
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024	Feb. 29	GL
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation	Feb. 21	GL
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules	Feb. 02	GL
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules	Feb. 02	AQ
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results	Nov. 09	GL
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023	23-10-30	GL
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023	23-10-30	AQ
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update	23-10-18	PR
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone	23-10-04	GL
Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone	23-10-04	AQ
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-08-23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Press Releases

Filters